Meeting
2023 ASCO Annual Meeting
Association of plant-based diet index with quality of life in patients with prostate cancer.
Authors
Stacy Loeb
New York University and Manhattan Veterans Affairs, New York, NY
Stacy Loeb , Qi Hua , Scott Bauer , Stacey A. Kenfield , Alicia K. Morgans , Lorelei A Mucci
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5037)
DOI
10.1200/JCO.2023.41.16_suppl.5037
Abstract #
5037
Poster Bd #
131
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Evaluating the contribution of virtual peer-led support to comprehensive prostate cancer (PCa ) care: The AnCan experience.
First Author: Herbert M. Geller
Poster
2024 ASCO Annual Meeting
ProstACT GLOBAL: A phase 3 study of best standard of care with and without 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer progressing despite prior treatment with a novel androgen axis drug.
First Author: Oliver Sartor
Poster
2024 ASCO Genitourinary Cancers Symposium
Relugolix versus leuprolide in combination with radiotherapy for localized prostate cancer (REVELUTION trial): An initial analysis of patient treatment preferences and quality of life.
First Author: Sagar A. Patel
Poster
2024 ASCO Genitourinary Cancers Symposium
Microboost dose escalation for localized prostate cancer within a statewide radiation oncology quality consortium.
First Author: Samuel Regan